Skip to main content
Equibles

Swiss National Bank

Bank

Position in IMVT — Immunovant, Inc.

CIK 1582202 ZURICH, V8
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$5,112,931
+$1,153,435 QoQ
Shares Held
132,700
-16.8% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 226 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. IMVT ranks #58 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 717,440 $356,373,971
2 REGN
Regeneron Pharmaceuticals, Inc.
 293,020 $182,709,690
3 ALNY
Alnylam Pharmaceuticals, Inc.
 374,080 $112,609,302
4 RVMD
Revolution Medicines, Inc.
 456,331 $85,461,669
5 RPRX
Royalty Pharma plc
 1,159,800 $65,029,986
6 INSM
INSMED Inc
 593,512 $63,280,249
7 INCY
Incyte Corp
 476,874 $54,058,436
8 MRNA
Moderna, Inc.
 679,900 $47,613,397

All Filings in IMVT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,112,931 132,700
2026-03-31 $3,959,496 159,400
2025-12-31 $4,023,986 158,300
2025-09-30 $2,137,512 132,600
2025-06-30 $2,076,800 129,800
2025-03-31 $2,249,044 131,600
2024-12-31 $2,496,816 100,800
2024-09-30 $2,839,596 99,600
2024-06-30 $2,629,440 99,600
2024-03-31 $3,218,076 99,600
2023-12-31 $4,196,148 99,600
2023-09-30 $4,956,149 129,100
2023-06-30 $2,151,198 113,400
2023-03-31 $1,296,636 83,600
2022-12-31 $1,659,625 93,500
2022-09-30 $530,658 95,100
2022-06-30 $370,890 95,100
2022-03-31 $524,001 95,100
2021-12-31 $755,724 88,700
2021-09-30 $656,964 75,600
2021-06-30 $799,092 75,600
2021-03-31 $1,243,100 77,500
2020-12-31 $3,579,725 77,500
2020-09-30 $2,611,098 74,200
2020-06-30 $1,256,460 51,600